Synthesis and heparanase inhibitory activity of sulfated mannooligosaccharides related to the antiangiogenic agent PI-88.

Bioorg Med Chem

Drug Design Group, Progen Pharmaceuticals Limited, PO Box 2403, Toowong, Qld 4066, Australia.

Published: January 2008

A stepwise synthetic route to the mannooligosaccharides from the neutral fraction of Pichia holstii phosphomannan hydrolysate, including a tetrasaccharylamine component, was developed using only two or three readily available d-mannose building blocks. These compounds were sulfonated to give the corresponding sulfated oligosaccharides which are closely related to the constituents of the anticancer agent PI-88. The synthetic approach is well suited to the preparation of analogues as demonstrated by the synthesis of a series of (1-->3)-linked mannooligosaccharides. The inhibitory activity of the sulfated oligosaccharides against heparanase was determined using a Microcon ultrafiltration assay. The tetra- and pentasaccharides were potent competitive inhibitors of heparanase (K(i)=200-280nM) whilst the shorter di- and trisaccharides were partial competitive inhibitors and did not completely inhibit the enzyme even at very high concentrations.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmc.2007.10.044DOI Listing

Publication Analysis

Top Keywords

inhibitory activity
8
activity sulfated
8
agent pi-88
8
sulfated oligosaccharides
8
competitive inhibitors
8
synthesis heparanase
4
heparanase inhibitory
4
sulfated mannooligosaccharides
4
mannooligosaccharides antiangiogenic
4
antiangiogenic agent
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!